Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315.
N Engl J Med. 2020.
PMID: 32492302
Free PMC article.
Clinical Trial.